Epilepsy trials recruiting in Kansas

All Epilepsy trials nationally

Cities in Kansas

Recruiting trials in Kansas

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Kansas: Kansas City
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
  NCT06063850 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Kansas: Kansas City
• Subcortical Arousal in Perceptual Awareness
  NCT06934356 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years and older · Sex: All (male and female) · Kansas: Kansas City